Tim Luker, Ph.D.
Associate Vice President, Venture Science, San Francisco
Tim Luker, Ph.D. is currently Associate Vice President, Venture Science leading Lilly's venture external innovation process on the west coast, primarily targeting transformational early-stage research across 5 therapeutic areas. In this role, Dr. Luker supports Lilly’s multiple external venture fund investments globally (~$2B) and due diligence and search and evaluation initiatives. To date, he has completed over 30 signed deals across multiple modalities and therapeutic areas for Lilly.
Dr. Luker is an experienced drug hunter with over 20 years of experience with over 60 patents and publications. Prior to joining Lilly, he held roles at Shire, AstraZeneca, and founded the acquired company, Polleo Pharma.
Dr. Luker earned his doctorate in chemistry from the University of Southampton, UK, carried out post-doctoral research at Universiteit Van Amsterdam, and is a Prince2 qualified project manager.
